BOLD-100 has a complex mechanism of action in cancer cells, with one of the major pathways being the prevention of the GRP78 upregulation, downstream activation of the UPR pathway, and subsequent cell death through caspase-8 activation [21], with minimal impact on normal human cell lines and primary cells [12]. Here, HSPA5 is linked to cancer.